Stock VEEV VEEVA SYSTEMS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Veeva Systems Inc.

Equities

VEEV

US9224751084

Advanced Medical Equipment & Technology

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
200.9 USD +0.91% Intraday chart for Veeva Systems Inc. +1.28% +4.36%
Apr. 24 Veeva Systems Insider Sold Shares Worth $681,116, According to a Recent SEC Filing MT
Apr. 16 Veeva Systems Insider Sold Shares Worth $746,297, According to a Recent SEC Filing MT

Valuation

Fiscal Period: Gennaio 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 21,784 41,871 36,371 26,553 33,396 32,470 - -
Enterprise Value (EV) 1 20,698 40,208 33,995 23,450 29,368 27,339 26,079 24,556
P/E ratio 77.2 x 117 x 89.9 x 56.9 x 64.4 x 48.7 x 44.5 x 37.3 x
Yield - - - - - - - -
Capitalization / Revenue 19.7 x 28.6 x 19.7 x 12.3 x 14.1 x 11.9 x 10.4 x 9.3 x
EV / Revenue 18.7 x 27.4 x 18.4 x 10.9 x 12.4 x 10 x 8.39 x 7.03 x
EV / EBITDA 47 x 65.7 x 43.2 x 27.3 x 33.6 x 24.9 x 20.9 x 17.2 x
EV / FCF 47.8 x 74.1 x 45.3 x 30.6 x 33.2 x 25 x 21.5 x 17.7 x
FCF Yield 2.09% 1.35% 2.21% 3.27% 3.01% 4.01% 4.66% 5.66%
Price to Book 13 x 18.4 x 12.5 x - 7.3 x 5.68 x 4.73 x 4.04 x
Nbr of stocks (in thousands) 148,587 151,466 153,764 155,688 161,016 161,614 - -
Reference price 2 146.6 276.4 236.5 170.6 207.4 200.9 200.9 200.9
Announcement Date 3/3/20 3/2/21 3/2/22 3/1/23 2/29/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Gennaio 2020 2021 2022 2023 2024 2025 2026 2027
Net sales 1 1,104 1,465 1,851 2,155 2,364 2,733 3,108 3,491
EBITDA 1 440.1 612.3 786.1 859.6 875.2 1,098 1,246 1,429
EBIT 1 412.2 582.8 758.7 830.5 842.5 1,070 1,233 1,424
Operating Margin 37.34% 39.78% 40.99% 38.54% 35.64% 39.16% 39.68% 40.78%
Earnings before Tax (EBT) 1 313.7 394 512.3 509.1 588 787.2 864.9 903.5
Net income 1 301.1 380 427.4 487.7 525.7 683.8 758.6 917.6
Net margin 27.27% 25.94% 23.09% 22.63% 22.24% 25.02% 24.41% 26.28%
EPS 2 1.900 2.360 2.630 3.000 3.220 4.126 4.512 5.387
Free Cash Flow 1 433.1 542.6 750.2 767 885.1 1,096 1,215 1,389
FCF margin 39.22% 37.03% 40.54% 35.59% 37.45% 40.09% 39.09% 39.78%
FCF Conversion (EBITDA) 98.41% 88.62% 95.44% 89.22% 101.14% 99.81% 97.51% 97.18%
FCF Conversion (Net income) 143.82% 142.78% 175.54% 157.26% 168.37% 160.22% 160.16% 151.37%
Dividend per Share 2 - - - - - - - -
Announcement Date 3/3/20 3/2/21 3/2/22 3/1/23 2/29/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: Gennaio 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1
Net sales 1 476.1 485.5 505.1 534.2 552.4 563.4 526.3 590.2 616.5 630.6 642.4 675.3 699.4 718.7 731.4
EBITDA 1 206.3 193.3 206.6 209.3 226.7 217.1 164.5 219.9 243 247.7 252.7 269.8 284.1 292.5 292.2
EBIT 1 199.4 186.3 199.6 202 219.5 209.4 157 211.8 234.6 239.1 246.2 263.5 277.3 284.6 287.6
Operating Margin 41.89% 38.36% 39.51% 37.82% 39.74% 37.16% 29.83% 35.89% 38.06% 37.91% 38.32% 39.02% 39.65% 39.6% 39.31%
Earnings before Tax (EBT) 1 133.5 119.5 130.4 109.5 133.9 135.4 91.78 142.9 170.7 182.7 182.6 197.9 213.4 215.9 -
Net income 1 105.9 97.1 100.1 90.6 108.5 188.5 131.5 111.6 135.2 147.4 163.2 168.6 177.8 185.5 180
Net margin 22.24% 20% 19.82% 16.96% 19.64% 33.46% 24.99% 18.91% 21.92% 23.37% 25.4% 24.97% 25.42% 25.81% 24.6%
EPS 2 0.6500 0.6000 0.6200 0.5600 0.6700 1.160 0.8100 0.6800 0.8300 0.9000 0.9817 1.018 1.070 1.094 1.134
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 12/1/21 3/2/22 6/1/22 8/31/22 12/1/22 3/1/23 5/31/23 8/30/23 12/6/23 2/29/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: Gennaio 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 - - - - - - - -
Net Cash position 1 1,087 1,664 2,376 3,103 4,028 5,131 6,391 7,914
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 433 543 750 767 885 1,096 1,215 1,389
ROE (net income / shareholders' equity) 23.9% 24.1% 23.4% 21% 18.9% 19.5% 18.2% 17.5%
ROA (Net income/ Total Assets) 15.3% 14.3% 17.6% 16.1% 14.8% 17.5% 17% 17.9%
Assets 1 1,963 2,659 2,425 3,022 3,561 3,913 4,453 5,135
Book Value Per Share 2 11.30 15.00 18.90 - 28.40 35.40 42.50 49.70
Cash Flow per Share 2 2.760 3.430 4.710 4.800 5.570 6.700 6.980 7.020
Capex 1 3.11 8.68 14.2 13.5 26.2 17.8 21.4 23
Capex / Sales 0.28% 0.59% 0.77% 0.63% 1.11% 0.65% 0.69% 0.66%
Announcement Date 3/3/20 3/2/21 3/2/22 3/1/23 2/29/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Veeva Systems Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
200.9 USD
Average target price
241.8 USD
Spread / Average Target
+20.36%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

1st Jan change Capi.
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
+4.36% 32.47B
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+14.14% 7.45B
SECTRA AB Stock Sectra AB
+22.93% 3.89B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-16.29% 3.15B
OMNICELL, INC. Stock Omnicell, Inc.
-25.96% 1.28B
LUNIT INC. Stock Lunit Inc.
-36.14% 1.09B
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-35.42% 902M
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
-0.13% 893M
VERADIGM INC. Stock Veradigm Inc.
-24.12% 857M
SURGICAL SCIENCE SWEDEN AB Stock Surgical Science Sweden AB
-18.47% 693M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. VEEV Stock
  4. Financials Veeva Systems Inc.